Altre lingue Indoco Remedies Limited

Azioni

INDOCO

INE873D01024

Tempo differito NSE India S.E. Altri mercati azionari 12:02:10 03/07/2024			Variaz. 5gg	Var. 1 gen.
344,8 ^INR	+0,01%		+5,67%	-12,74%

06/06	Indoco Remedies ottiene l'approvazione provvisoria della FDA statunitense per il farmaco generico per il diabete di tipo 2	MT
06/06	Indoco Remedies riceve dall'USFDA l'approvazione provvisoria ANDA per Canagliflozin e Metformina cloridrato compresse	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Indoco Remedies Faces Potential GST Demand of INR 0.282 Million from Office of the Joint Commissioner State Tax Special Circle , Ranchi	19/06
Indoco Remedies Gets US FDA's Tentative Approval for Generic Type 2 Diabetes Drug	06/06
Indoco Remedies Receives Tentative ANDA Approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets	06/06
Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules	22/05
Indoco Remedies Ltd. Receives Final ANDA Approval from USFDA for Pregabalin Capsules	21/05
Indoco Remedies Limited Receives Show Cause Notice from Office of the Joint Commissioner of State Tax Patna Special Circle, Patna Bihar	18/05
Indoco Remedies Gets Zero Observations from US FDA for Navi Mumbai, India Plant, IAS Division	16/05
Indoco Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	16/05
Indoco Remedies Limited Receives Show Cause Notice Received from the Goods and Service Tax Authority	10/05
Indoco Remedies Limited Announces Cessation of Divakar M. Gavaskar and Rajiv P. Kakodkar as Independent Directors, Effective Mach 31, 2024	29/03
Indoco Remedies Arm Begins Commercial Production from New Manufacturing Unit	26/03
Indoco Remedies to Buy Land in Mumbai for Expansion	12/03
Indoco Remedies Arm Begins Commercial Production at New Oral Care Unit	04/03
Indoco Remedies' Consolidated Profit Slumps in Fiscal Q3; Shares Drop 6%	23/01
Indoco Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01
Indoco Remedies Gets Establishment Inspection Report from US FDA after Goa Unit Inspection	18/01
Indoco Remedies Gets Tentative US FDA Nod for Generic Diabetes Drug	06/12
Indoco Remedies Receives Tentative ANDA Approval from USFDA for Canagliflozin Tablets	06/12
Indoco Remedies' Solid Oral Formulation Plant in Goa, India, Gets Four Observations from US FDA	20/10/23
Indoco Remedies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	19/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Indoco Remedies Limited

Azioni

INDOCO

INE873D01024

Altre lingue

Filtri